Research Interest
With 25 years of leadership experience across the pharmaceutical and biotech sectors—including entrepreneurial ventures—I specialize in translating early scientific ideas into commercial assets. My expertise spans the drug discovery spectrum, including pharmacological evaluation of novel therapeutic modalities, structural biology, and data management.
Since 2025, I have led the Biochemical and Cellular Assay unit within SciLifeLab’s Drug Discovery and Development (DDD) platform. We provide microplate-based enzymatic and cellular assay technologies to evaluate newly synthesized small molecules and biologics. Our data drives structure–activity relationship (SAR) studies, enabling iterative design cycles for novel molecular entities.
Group Members
- Hjalmar Gullberg
- Katharina Klöditz
- Melania Minoia
- Natalia Nekhotieva